Ingemar Turesson

2022

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls

Shah, U. A., Rögnvaldsson, S., Derkach, A., Björkholm, M., Turesson, I., David, Y., Hultcrantz, M., Tan, C., Hassoun, H., Korde, N., Lesokhin, A., Mailankody, S., Kristinsson, S. Y. & Ola Landgren, C., 2022 Jan, In: Haematologica. 107, 1, p. 284-286 3 p.

Research output: Contribution to journal › Letter › peer-review

Open Access

Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

Blimark, C. H., Vangsted, A. J., Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), 2022, In: European Journal of Haematology. 108, 2, p. 99-108

Research output: Contribution to journal › Article › peer-review

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

Wålinder, G., Genell, A., Juliusson, G., Svensson, R., Santamaria, A. I., Crafoord, J., Carlson, K., Knut-Bojanowska, D., Veskovski, L., Lauri, B., Lund, J., Turesson, I., Hansson, M., Blimark, C. H. & Nahi, H., 2022 Nov, In: Cancer Reports. 5, 11, e1614.

Research output: Contribution to journal › Article › peer-review

Open Access

2021

A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era

Steingrímsson, V., Gíslason, G. K., Þorsteinsdóttir, S., Rögnvaldsson, S., Gottfreðsson, M., Aspelund, T., Turesson, I., Björkholm, M., Landgren, O. & Kristinsson, S. Y., 2021, In: European Journal of Haematology. 106, 3, p. 346-353

Research output: Contribution to journal › Article › peer-review

Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance

Baldursdóttir, T. R., Löve, Þ. J., Gíslason, G. K., Björkholm, M., Mellqvist, U. H., Lund, S. H., Blimark, C. H., Turesson, I., Hultcrantz, M., Landgren, O. & Kristinsson, S. Y., 2021, In: European Journal of Haematology. 106, 3, p. 380-388

Research output: Contribution to journal › Article › peer-review

Comorbidities in multiple myeloma and implications on survival: A population-based study

Sverrisdóttir, I. S., Rögnvaldsson, S., Thorsteinsdottir, S., Gíslason, G. K., Aspelund, T., Turesson, I., Björkholm, M., Gregersen, H., Hveding Blimark, C., Landgren, O. & Kristinsson, S. Y., 2021, In: European Journal of Haematology. 106, 6, p. 774-782

Research output: Contribution to journal › Article › peer-review

Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma

Jonsdottir, G., Björkholm, M., Turesson, I., Hultcrantz, M., Diamond, B., Porwit, A., Landgren, O. & Kristinsson, S. Y., 2021, In: European Journal of Haematology. 107, 2, p. 275-282

Research output: Contribution to journal › Article › peer-review

Germline variants at SOHLH2 influence multiple myeloma risk

Duran-Lozano, L., Thorleifsson, G., Lopez de Lapuente Portilla, A., Niroula, A., Went, M., Thodberg, M., Pertesi, M., Ajore, R., Cafaro, C., Olason, P. I., Stefansdottir, L., Bragi Walters, G., Halldorsson, G. H., Turesson, I., Kaiser, M. F., Weinhold, N., Abildgaard, N., Andersen, N. F., Mellqvist, U-H., Waage, A., & 7 othersJuul-Vangsted, A., Thorsteinsdottir, U., Hansson, M., Houlston, R., Rafnar, T., Stefansson, K. & Nilsson, B., 2021 Apr 19, In: Blood Cancer Journal. 11, 4, 76.

Research output: Contribution to journal › Article › peer-review

Open Access

Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study

Rögnvaldsson, S., Aspelund, T., Thorsteinsdóttir, S., Turesson, I., Björkholm, M., Landgren, O. & Kristinsson, S. Y., 2021 Jul 1, In: European Journal of Haematology. 107, 1, p. 137-144 8 p.

Research output: Contribution to journal › Article › peer-review

2020

A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival

Steingrímsson, V., Gíslason, G. K., Aspelund, T., Turesson, I., Björkholm, M., Landgren, O. & Kristinsson, S. Y., 2020, In: European Journal of Haematology. 105, 5, p. 547-554

Research output: Contribution to journal › Article › peer-review

Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels

Heaney, J. L. J., Richter, A., Bowcock, S., Pratt, G., Anthony Child, J., Jackson, G., Morgan, G., Turesson, I. & Drayson, M. T., 2020 Apr, In: Haematologica. 105, 4, p. E169-E171

Research output: Contribution to journal › Letter › peer-review

Monoclonal gammopathy of undetermined significance in medical hospital admissions – a new strategy for screening?

Turesson, I., 2020, In: British Journal of Haematology. 189, 6, p. 1010-1011

Research output: Contribution to journal › Debate/Note/Editorial

Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Wålinder, G., Samuelsson, J., Näsman, P., Hansson, M., Juliusson, G., Forsberg, K., Svensson, R., Linder, O., Carlson, K., Kristinsson, S. Y., Mellqvist, U. H., Hveding Blimark, C., Turesson, I. & Nahi, H., 2020, In: European Journal of Haematology. 104, 5, p. 376-382 7 p.

Research output: Contribution to journal › Article › peer-review

Second malignancies in multiple myeloma; emerging patterns and future directions

Maclachlan, K., Diamond, B., Maura, F., Hillengass, J., Turesson, I., Landgren, C. O. & Kazandjian, D., 2020 Mar, In: Best Practice and Research: Clinical Haematology. 33, 1, 101144.

Research output: Contribution to journal › Review article › peer-review

2019

Association of Immune Marker Changes with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Landgren, O., Hofmann, J. N., McShane, C. M., Santo, L., Hultcrantz, M., Korde, N., Mailankody, S., Kazandjian, DI., Murata, K., Thoren, K., Ramanathan, L., Dogan, A., Rustad, E., Lu, S. X., Akhlaghi, T., Kristinsson, S. Y., Björkholm, M., Devlin, S., Purdue, M. P., Pfeiffer, R. M., & 1 othersTuresson, I., 2019 Jul 18, In: JAMA Oncology.

Research output: Contribution to journal › Article › peer-review

Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study

Sverrisdóttir, I. S., Lund, S. H., Turesson, I., Björkholm, M., Goldin, L. R., Landgren, O. & Kristinsson, S. Y., 2019, In: British Journal of Haematology. 186, 1, p. 37-44

Research output: Contribution to journal › Article › peer-review

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden

Ali, M., Lemonakis, K., Wihlborg, A-K., Veskovski, L., Turesson, I., Mellqvist, U-H., Gullberg, U., Hansson, M. & Nilsson, B., 2019 Jul 30, In: Blood Cancer Journal. 9, 8, 57.

Research output: Contribution to journal › Letter › peer-review

Open Access

2018

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes

Westhrin, M., Moen, S. H., Kristensen, I. B., Buene, G., Mylin, A. K., Turesson, I., Abildgaard, N., Waage, A. & Standal, T., 2018 Jun 14, In: Biomarker research. 6, 1, 21.

Research output: Contribution to journal › Letter › peer-review

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

Usmani, S. Z., Hoering, A., Cavo, M., Miguel, J. S., Goldschimdt, H., Hajek, R., Turesson, I., Lahuerta, J. J., Attal, M., Barlogie, B., Lee, J. H., Kumar, S., Lenhoff, S., Morgan, G., Rajkumar, S. V., Durie, B. G. M. & Moreau, P., 2018, In: Blood Cancer Journal. 8, 12

Research output: Contribution to journal › Article › peer-review

Open Access

Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry

Blimark, C. H., Turesson, I., Genell, A., Ahlberg, L., Björkstrand, B., Carlson, K., Forsberg, K., Juliusson, G., Linder, O., Mellqvist, U. H., Nahi, H. & Kristinsson, S. Y., 2018 Feb 28, In: Haematologica. 103, 3, p. 506-513

Research output: Contribution to journal › Article › peer-review

Open Access

Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

Turesson, I., Bjorkholm, M., Blimark, C. H., Kristinsson, S., Velez, R. & Landgren, O., 2018 Aug 1, In: European Journal of Haematology. 101, 2, p. 237-244 8 p.

Research output: Contribution to journal › Review article › peer-review

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

Ali, M., Ajore, R., Wihlborg, A. K., Niroula, A., Swaminathan, B., Johnsson, E., Stephens, O. W., Morgan, G., Meissner, T., Turesson, I., Goldschmidt, H., Mellqvist, U. H., Gullberg, U., Hansson, M., Hemminki, K., Nahi, H., Waage, A., Weinhold, N. & Nilsson, B., 2018 Dec 1, In: Nature Communications. 9, 1, 1649.

Research output: Contribution to journal › Article › peer-review

Open Access

2017

Direct evidence for a polygenic etiology in familial multiple myeloma

Halvarsson, B-M., Wihlborg, A-K., Ali, M., Lemonakis, K., Johnsson, E., Niroula, A., Cibulskis, C., Weinhold, N., Försti, A., Alici, E., Langer, C., Pfreundschuh, M., Goldschmidt, H., Mellqvist, U-H., Turesson, I., Waage, A., Hemminki, K., Golub, T., Nahi, H., Gullberg, U., & 2 othersHansson, M. & Nilsson, B., 2017 Apr 11, In: Blood Advances. 1, 10, p. 619-623

Research output: Contribution to journal › Article › peer-review

Open Access

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Juliusson, G., Karin, F., Hansson, M., Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Turesson, I., 2017 Sept, In: European Journal of Haematology. 99, 3, p. 216-222

Research output: Contribution to journal › Article › peer-review

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., Oriol, A., Cavo, M., Ocio, E. M., Mateos, M. V., O'Donnell, E. K., Vij, R., Lokhorst, H. M., van de Donk, N. W. C. J., Cam-min, J., Mark, T., Turesson, I., & 21 othersHansson, M., Jagannath, S., Delforge, M., Kyriakou, C., Hari, P., Mellqvist, U. H., Usmani, S. Z., Dytfeld, D., Badros, A. Z., Otero, P. R., Shustik, C., Waller, D., Chng, W-J., Ozaki, S., de la Rubia, J., Eom, H. S., Rosinol, L., Lahuerta, J. J., Sureda, A., Kim, J. S. & Durie, B. G. M., 2017, In: Leukemia. 31, p. 2443-2448

Research output: Contribution to journal › Article › peer-review

2016

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B-M., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Campo, C., Einsele, H., Gregory, W. A., Gullberg, U., Henrion, M., & 38 othersHillengass, J., Hoffmann, P., Jackson, G. H., Johnsson, E., Jöud, M., Kristinsson, S. Y., Lenhoff, S., Lenive, O., Mellqvist, U-H., Migliorini, G., Nahi, H., Nelander, S., Nickel, J., Nöthen, M. M., Rafnar, T., Ross, F. M., da Silva Filho, M. I., Swaminathan, B., Thomsen, H., Turesson, I., Vangsted, A., Vogel, U., Waage, A., Walker, B. A., Wihlborg, A-K., Broyl, A., Davies, F. E., Thorsteinsdottir, U., Langer, C., Hansson, M., Kaiser, M., Sonneveld, P., Stefansson, K., Morgan, G. J., Goldschmidt, H., Hemminki, K., Nilsson, B. & Houlston, R. S., 2016, In: Nature Communications. 7, 12050.

Research output: Contribution to journal › Article › peer-review

Open Access

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.

Vélez, R., Turesson, I., Landgren, O., Kristinsson, S. Y. & Cuzick, J., 2016, In: BMJ Open. 6, p. e009584

Research output: Contribution to journal › Article › peer-review

Open Access

Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.

Laubach, J., Garderet, L., Mahindra, A., Gahrton, G., Caers, J., Sezer, O., Voorhees, P., Leleu, X., Johnsen, H. E., Streetly, M., Ludwig, H., Mellqvist, U-H., Chng, W-J., Pilarski, L., Einsele, H., Hou, J., Turesson, I., Zamagni, E., Chim, J., Mazumder, A., & 16 othersWestin, J., Lu, J., Reiman, T., Kristinsson, S., Joshua, D., Roussel, M., O'Gorman, P., Terpos, E., Dimopoulos, M., Moreau, P., Anderson, K., Palumbo, A., Kumar, S., Rajkumar, V., Durie, B. & Richardson, P., 2016, In: Leukemia. 30, p. 1005-1017

Research output: Contribution to journal › Review article › peer-review

Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.

Jonsdottir, G., Lund, S. H., Björkholm, M., Turesson, I., Wahlin, A., Mailankody, S., Blimark, C., Hultcrantz, M., Porwit, A., Landgren, O. & Kristinsson, S. Y., 2016, In: Haematologica. 101, p. e145-e148

Research output: Contribution to journal › Article › peer-review

Open Access

2015

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.

Olsen, O. E., Wader, K. F., Hella, H., Mylin, A. K., Turesson, I., Nesthus, I., Waage, A., Sundan, A. & Holien, T., 2015, In: Cell Communication and Signaling. 13, 1, 27.

Research output: Contribution to journal › Article › peer-review

Open Access

File

165 Downloads (Pure)

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Giralt, S., Garderet, L., Durie, B., Cook, G., Gahrton, G., Bruno, B., Hari, P., Lokhorst, H., McCarthy, P., Krishnan, A., Sonneveld, P., Goldschmidt, H., Jagannath, S., Barlogie, B., Mateos, M., Gimsing, P., Sezer, O., Mikhael, J., Lu, J., Dimopoulos, M., & 45 othersMazumder, A., Palumbo, A., Abonour, R., Anderson, K., Attal, M., Blade, J., Bird, J., Cavo, M., Comenzo, R., de la Rubia, J., Einsele, H., Garcia-Sanz, R., Hillengass, J., Holstein, S., Johnsen, H., Joshua, D., Koehne, G., Kumar, S., Kyle, R., Leleu, X., Lonial, S., Ludwig, H., Nahi, H., Nooka, A., Orlowski, R., Rajkumar, V., Reiman, A., Richardson, P., Rivas, E., San Miguel, J., Turesson, I., Usmani, S., Vesole, D., Bensinger, W., Qazilbash, M., Efebera, Y., Mohty, M., Gasparreto, C., Gajewski, J., LeMaistre, C. F., Bredeson, C., Moreau, P., Pasquini, M., Kroeger, N. & Stadtmauer, E., 2015, In: Biology of Blood and Marrow Transplantation. 21, 12, p. 2039-2051

Research output: Contribution to journal › Article › peer-review

Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups

Beksac, M., Waage, A., Bringhen, S., Kristinsson, S. Y., Sucak, G. T., Gimsing, P., Lupparelli, G., Firatli-Tuglular, T., Juliusson, G., Turesson, I. & Palumbo, A., 2015, In: Acta Haematologica. 133, 4, p. 372-380

Research output: Contribution to journal › Article › peer-review

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

Westhrin, M., Moen, S. H., Holien, T., Mylin, A. K., Heickendorff, L., Olsen, O. E., Sundan, A., Turesson, I., Gimsing, P., Waage, A. & Standal, T., 2015, In: Haematologica. 100, 12, p. E511-E514

Research output: Contribution to journal › Letter › peer-review

Open Access

File

207 Downloads (Pure)

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Blimark, C., Holmberg, E., Mellqvist, U-H., Landgren, O., Björkholm, M., Hultkrantz, M. L., Kjellander, C., Turesson, I. & Kristinsson, S. Y., 2015, In: Haematologica. 100, 1, p. 107-113

Research output: Contribution to journal › Article › peer-review

Open Access

File

489 Downloads (Pure)

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Steingrímsson, V., Lund, S. H., Turesson, I., Goldin, L. R., Björkholm, M., Landgren, O. & Kristinsson, S. Y., 2015, In: Blood. 125, 13, p. 2174-2175

Research output: Contribution to journal › Letter

The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.

Sigurdardottir, E. E., Turesson, I., Lund, S. H., Lindqvist, E. K., Mailankody, S., Korde, N., Björkholm, M., Landgren, O. & Kristinsson, S. Y., 2015, In: JAMA Oncology. 1, 2, p. 168-174

Research output: Contribution to journal › Article › peer-review

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Swaminathan, B., Thorleifsson, G., Jöud, M., Ali, M., Johnsson, E., Ajore, R., Sulem, P., Halvarsson, B-M., Eyjolfsson, G., Haraldsdottir, V., Hultman, C., Ingelsson, E., Kristinsson, S. Y., Kähler, A. K., Lenhoff, S., Masson, G., Mellqvist, U-H., Månsson, R., Nelander, S., Olafsson, I., & 14 othersSigurðardottir, O., Steingrimsdóttir, H., Vangsted, A., Vogel, U., Waage, A., Nahi, H., Gudbjartsson, D. F., Rafnar, T., Turesson, I., Gullberg, U., Stefánsson, K., Hansson, M., Thorsteinsdóttir, U. & Nilsson, B., 2015, In: Nature Communications. 6, p. 1-8 7213.

Research output: Contribution to journal › Article › peer-review

Open Access

File

204 Downloads (Pure)

2014

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Olsen, O. E., Wader, K. F., Misund, K., Våtsveen, T. K., Rø, T. B., Mylin, A. K., Turesson, I., Størdal, B. F., Moen, S. H., Standal, T., Waage, A., Sundan, A. & Holien, T., 2014, In: Blood Cancer Journal. 4, Mar 21, p. e196

Research output: Contribution to journal › Article › peer-review

File

145 Downloads (Pure)

Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Turesson, I., Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, In: Journal of Thrombosis and Haemostasis. 12, 11, p. 1816-1821

Research output: Contribution to journal › Article › peer-review

Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.

Turesson, I., Kovalchik, S. A., Pfeiffer, R. M., Kristinsson, S. Y., Goldin, L. R., Drayson, M. T. & Landgren, O., 2014, In: Blood. 123, 3, p. 338-345

Research output: Contribution to journal › Article › peer-review

Open Access

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

Ocio, E. M., Richardson, P. G., Rajkumar, S. V., Palumbo, A., Mateos, M. V., Orlowski, R., Kumar, S., Usmani, S., Roodman, D., Niesvizky, R., Einsele, H., Anderson, K. C., Dimopoulos, M. A., Avet-Loiseau, H., Mellqvist, U-H., Turesson, I., Merlini, G., Schots, R., McCarthy, P., Bergsagel, L., & 14 othersChim, C. S., Lahuerta, J. J., Shah, J., Reiman, A., Mikhael, J., Zweegman, S., Lonial, S., Comenzo, R., Chng, W. J., Moreau, P., Sonneveld, P., Ludwig, H., Durie, B. G. M. & Miguel, J. F. S., 2014, In: Leukemia. 28, 3, p. 525-542

Research output: Contribution to journal › Review article › peer-review

Robust isolation of malignant plasma cells in multiple myeloma.

Frigyesi, I., Adolfsson, J., Ali, M., Christophersen, M. K., Johnsson, E., Turesson, I., Gullberg, U., Hansson, M. & Nilsson, B., 2014, In: Blood. 123, 9, p. 1336-1340

Research output: Contribution to journal › Article › peer-review

2013

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Mellqvist, U-H., Gimsing, P., Hjertner, O., Lenhoff, S., Laane, E., Remes, K., Steingrimsdottir, H., Abildgaard, N., Ahlberg, L., Blimark, C., Dahl, I. M., Forsberg, K., Gedde-Dahl, T., Gregersen, H., Gruber, A., Guldbrandsen, N., Haukas, E., Carlson, K., Kvam, A. K., Nahi, H., & 5 othersLindas, R., Andersen, N. F., Turesson, I., Waage, A. & Westin, J., 2013, In: Blood. 121, 23, p. 4647-4654

Research output: Contribution to journal › Article › peer-review

Open Access

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.

Terpos, E., Morgan, G., Dimopoulos, M. A., Drake, M. T., Lentzsch, S., Raje, N., Sezer, O., García-Sanz, R., Shimizu, K., Turesson, I., Reiman, T., Jurczyszyn, A., Merlini, G., Spencer, A., Leleu, X., Cavo, M., Munshi, N., Rajkumar, S. V., Durie, B. G. M. & Roodman, G. D., 2013, In: Journal of Clinical Oncology. 31, 18, p. 2347-U179

Research output: Contribution to journal › Article › peer-review

Patterns of survival in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: A population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005

Kristinsson, S. Y., Eloranta, S., Dickman, P. W., Andersson, T. M-L., Turesson, I., Landgren, O. & Bjorkholm, M., 2013, In: American Journal of Hematology. 88, 1, p. 60-65

Research output: Contribution to journal › Article › peer-review

2012

Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia with Solid Tumors and Myeloid Malignancies

Kristinsson, S. Y., Goldin, L. R., Turesson, I., Bjorkholm, M. & Landgren, O., 2012, In: Acta Haematologica. 127, 3, p. 173-177

Research output: Contribution to journal › Review article › peer-review

File

131 Downloads (Pure)

Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

Kristinsson, S. Y., Goldin, L., Turesson, I., Hultcrantz, M., Björkholm, M. & Landgren, O., 2012, In: Journal of Thrombosis and Haemostasis. 10, 5, p. 962-964

Research output: Contribution to journal › Letter › peer-review

Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study

Kristinsson, S. Y., Tang, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Blimark, C., Mellqvist, U-H., Wahlin, A., Turesson, I. & Landgren, O., 2012, In: Haematologica. 97, 6, p. 854-858

Research output: Contribution to journal › Article › peer-review

Open Access

MyelomA Genetics International Consortium

Morgan, G., Johnsen, H. E., Goldschmidt, H., Palumbo, A., Cavo, M., Sonneveld, P., San Miguel, J., Chim, C. S., Browne, P., Einsele, H., Waage, A., Turesson, I., Spencer, A., Hajek, R., Ludwig, H., Hemminki, K. & Houlston, R., 2012, In: Leukemia & Lymphoma. 53, 5, p. 796-800

Research output: Contribution to journal › Review article › peer-review

Second malignancies after multiple myeloma: from 1960s to 2010s

Thomas, A., Mailankody, S., Korde, N., Kristinsson, S. Y., Turesson, I. & Landgren, O., 2012, In: Blood. 119, 12, p. 2731-2737

Research output: Contribution to journal › Review article › peer-review

File

143 Downloads (Pure)

Ingemar Turesson

Research output

Search results